Improving Postural Control Through Innovative Stimulation of the Proprioceptive System (IMPULSES)

Every movement humans make in everyday life is based on a continuous integration of sensory information. A good interaction between sensory processes and motor control, called sensorimotor integration, is necessary for the efficiency of movements. Sensorimotor integration in the context of posture and walking is based on proprioception. Proprioception is the conscious and unconscious perception of the spatial and mechanical state of the musculoskeletal system. Proprioceptive information transmitted through the neuromuscular spindles in particular is suggested to play a role in motor rehabilitation.

Study Overview

Detailed Description

This is particularly important when considering populations with impaired proprioception resulting in impaired posture and gait control. This is particularly the case for older adults and children with cerebral palsy (CP). Nevertheless, drastic differences exist between the two populations in the nature of these alterations: stable (children with CP) vs. progressive (older adults); brain lesion/upper motor neuron (children with CP) vs. processing deficits and peripheral sensory degradation (older adults); growing (children with CP) vs. fully developed individuals (older adults). However, both populations can improve their postural control with postural exercise programmes. In humans, the proprioceptive system can also be stimulated non-invasively by mechanical vibrations applied to tendons or muscles (localised vibration; LV), or by electrical stimulation of peripheral nerves (somatosensory electrical stimulation; SES). As a result, chronically applied SES can improve sensorimotor function in healthy adults and some clinical cohorts. Similarly, a 6-week weight-bearing and weight-shifting training programme combined with LV has been reported to provide improved benefits in postural control, again in stroke patients.The greater improvement in motor function when LV or SES is added to active muscles may reflect an adjuvant effect: the sensory signal from LV or SES stimulation is integrated with the sensory signals from the task being performed, thus acting as an associative conditioning of the proprioceptive system, and leading to improved sensorimotor integration. The present project aims to study the effectiveness of a short-term intervention combining postural exercises with LV, SES, or the combination of both.

In particular, this study will focus on the effects of these interventions on proprioception, postural control and walking in children with CP and older adults.Confirmation of hypotheses will open up new avenues for rehabilitation therapies and preventive interventions, and may be extended to other purposes and clinical populations.

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Étienne, France, 42055
        • CENTRE HOSPITALIER DE SAINT-ETIENNE

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Older Adults:

  • Affiliated or beneficiaries of a social security plan
  • Who have freely given their written consent after having been informed of the purpose, the procedure and the potential risks involved

Children with Cerebral Palsy:

  • Children between the ages of 7 and 18 years, diagnosed with Spastic Cerebral Palsy, presenting with a clinical picture of infantile cerebral hemiplegia or diplegia.
  • Children able to understand and follow the simple instructions of the examination
  • Children walking GMFCS (Gross Motor Functional Classification system) I to II.
  • Children with at least one parent and the child having given and signed the consent agreement
  • Children who are members or beneficiaries of a social security system

Exclusion Criteria:

Older adults:

  • Pathology or surgery resulting in a locomotor disorder, within 6 months prior to the study,
  • Chronic neurological, motor or psychological pathologies
  • Use of neuro-active substances likely to alter cortico-spinal excitability (hypnotics, anti-epileptics, psychotropic drugs, muscle relaxants) during the study.
  • Contraindication to transcranial magnetic stimulation:

    • Cardiac or respiratory insufficiency.
    • Wearing a cardiac pace maker.
    • Wearing a heart valve and severe cardiovascular diseases.
    • Presence of prosthetic material or ferromagnetic foreign bodies in the head.
    • Presence of cochlear implants or ocular prosthetic material.
    • History of neurosurgical procedures.
    • Neurological diseases that may affect brain structures and cognitive abilities (e.g., intracranial tumor, multiple sclerosis, history of stroke or head injury).
  • Participation at the same time in another interventional trial or having participated in a such a study within 30 days prior to this study.
  • Obesity (body mass index ≥ 30.0 kg/m²)

Children with cerebral palsy:

  • Children with concomitant muscle disease (e.g., myopathy...).
  • Children who have received a baclofen injection in the 6 months preceding the evaluation.
  • Children who have undergone neuro-orthopedic surgery on the lower limbs within the last 6 months
  • Children who have received a botulinum toxin injection within the last 6 months
  • Children participating in therapeutic programs other than their usual physical therapy sessions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: POSTUR
Postural training only.
Training sessions without any stimulation
Other: POSTUR + LV (localized vibration)
Postural training combined with localized vibration
Training sessions without any stimulation
Training sessions with localized vibration
Other: POSTUR+SES (somatosensory electrical stimulation)
Postural training combined with somatosensory electrical stimulation
Training sessions without any stimulation
Training sessions with somatosensory electrical stimulation
Other: POSTUR+LV-SES
Postural training combined with somatosensory electrical stimulation and localized vibration
Training sessions without any stimulation
Training sessions with localized vibration
Training sessions with somatosensory electrical stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of body balance with the Berg Balance Scale (BBS)
Time Frame: Change from Week 8 to Week 16
Variation of postural control
Change from Week 8 to Week 16

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of body balance with the Berg Balance Scale (BBS)
Time Frame: Change from Week 1 to Week 22
Variation of postural control
Change from Week 1 to Week 22
Evaluation of the displacement of the center of pressure with force platform in centimeter
Time Frame: Change from Week 1 to Week 22
Variation of postural control
Change from Week 1 to Week 22
Displacement of the centrer of pressure with application of localized vibration in centimeter
Time Frame: Change from Week 1 to Week 22
Proprioceptive contribution to postural control
Change from Week 1 to Week 22
Measure of the angular position error in degrees
Time Frame: Change from Week 1 to Week 22
Variation of the position direction
Change from Week 1 to Week 22
Coefficient of variation muscle force control in percent
Time Frame: Change from Week 1 to Week 22
Muscle force control measurement
Change from Week 1 to Week 22
Measure 6-minute walk test (6MWT) in meters
Time Frame: Change from Week 1 to Week 22
Walking ability evaluation
Change from Week 1 to Week 22
Measure Timed Up & Go Test (TUG) in seconds
Time Frame: Change from Week 1 to Week 22
Walking ability evaluation
Change from Week 1 to Week 22
Measure 10 meter walk test (10MWT) in seconds
Time Frame: Change from Week 1 to Week 22
Walking ability evaluation
Change from Week 1 to Week 22
Quantifying corticospinal excitability with motor evoked potentials in milliVolt
Time Frame: Change from Week 1 to Week 22
Underlying neural adaptations evaluation in older adults only
Change from Week 1 to Week 22
Quantifying spinal excitability with H-reflex in milliVolt
Time Frame: Change from Week 1 to Week 22
Underlying neural adaptations evaluation in older adults only
Change from Week 1 to Week 22

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Léonard FEASSON, PHD, CHU de Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 29, 2022

Primary Completion (Actual)

February 7, 2024

Study Completion (Actual)

July 22, 2024

Study Registration Dates

First Submitted

May 2, 2022

First Submitted That Met QC Criteria

May 5, 2022

First Posted (Actual)

May 10, 2022

Study Record Updates

Last Update Posted (Actual)

July 29, 2024

Last Update Submitted That Met QC Criteria

July 26, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 21CH160
  • 2021-A02416-35 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sensorimotor Disorder

Subscribe